|
|
#1
08-07-2015, 03:40 AM
|
|||
|
|||
Allergan CEO says better to leave discoveries to others
Aug 6 (Reuters) - Allergan, which is selling its generics business to focus on branded ***** and aesthetics products, aims to acquire or license products that have already shown promise in studies, and leave the riskier discovery process to small biotechs and academic researchers.  ??????? ??????: Allergan CEO says better to leave discoveries to others || ??????: ahlam1399 || ??????: اسم منتداك
|
 |
|
|
العرض العادي
